首页 | 本学科首页   官方微博 | 高级检索  
检索        

新辅助化疗对乳腺癌bcl-2、bax基因表达影响的研究
引用本文:李永清,王永胜,刘延冰,赵桐,李济宇,陈鹏.新辅助化疗对乳腺癌bcl-2、bax基因表达影响的研究[J].实用癌症杂志,2006,21(3):263-265.
作者姓名:李永清  王永胜  刘延冰  赵桐  李济宇  陈鹏
作者单位:250117,山东省肿瘤医院乳腺病中心
摘    要:目的探讨新辅助化疗对乳腺癌组织中相关癌基因bcl-2、bax表达的影响。方法采用免疫组化LSAB法进行化疗前后肿瘤组织bcl-2、bax基因蛋白表达的检测,并与临床研究对照。结果4种不同化疗方案临床效果不同,CMF方案有效率为66.7%,CEF方案有效率为87.5%,CAF方案有效率为82.4%,NA方案有效率为100%。4种不同化疗方案均使bax与bcl-2蛋白化疗后表达增水平高。结论新辅助化疗使癌基因bcl-2、bax表达增强。

关 键 词:乳腺肿瘤  新辅助化疗  bcl-2基因  bax基因  细胞调亡
文章编号:1001-5930(2006)03-0263-03
收稿时间:2006-03-28
修稿时间:2006-04-19

Study on Neoadjuvant Chemotherapy Influence the Expression of bcl-2 and Bax on Breast Cancer
LI Yong-qing , WANG Yong-sheng , LIU Yan-bing , et al.Study on Neoadjuvant Chemotherapy Influence the Expression of bcl-2 and Bax on Breast Cancer[J].The Practical Journal of Cancer,2006,21(3):263-265.
Authors:LI Yong-qing  WANG Yong-sheng  LIU Yan-bing  
Institution:Breast Diease Center of Shandong Toumer Hospital ,Jinan ,250117
Abstract:Objective To study the change of clinical and pathologic and the expression of bcl-2 and bax in tissue of breast cancer between preneoadjuvant chemotherapy and postneoadjuvantchemotherapy.Methods LSAB was used to detect the expression of bcl-2 and bax in the tissue of breast cancer including preneoadjuvant chemotherapy and postneoadjuvant chemotherapy,and compared with clinical studies.Results These four chemotherapy projects had different clinical resolution rate.Rates of CMF and CEF were 66.7% and 87.5% respectively,and in CAF and NA were 82.4% and 100% respectively.These four chemotherapy projects all increased the expression of bcl-2 and bax in the tissue of postneoadjuvant chemotherapy.Conclusion Neoadjuvant chemotherapy increased the expression of bcl-2 and bax.
Keywords:Breast cancer  Neoadjuvant chemotherapy  bcl-2 gene  bax gene  Apoptosis
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号